| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/22/2012 | EP2420511A1 Peptide having activity of transforming growth factor and production method therefor |
| 02/22/2012 | EP2420510A1 Nicotinoyl peptide derivatives and cosmetic composition comprising the same |
| 02/22/2012 | EP2420509A2 Novel marker genes for regulatory T cells from human blood |
| 02/22/2012 | EP2420253A1 Engineering multifunctional and multivalent molecules with collagen XV trimerization domain |
| 02/22/2012 | EP2420248A1 Mutated HIV NEF for modulating immunity |
| 02/22/2012 | EP2420247A1 Adenovirus formulations |
| 02/22/2012 | EP2420246A1 Methods and compositions based on shiga toxin type 1 protein |
| 02/22/2012 | EP2419534A1 Signature of secreted protein isoforms specific to ovarian cancer |
| 02/22/2012 | EP2419513A2 Regulation of aging by modulation of mitochondrial function |
| 02/22/2012 | EP2419512A1 Method of screening for insulin secretion-potentiating agents |
| 02/22/2012 | EP2419451A1 Antibodies against prostate specific membrane antigen |
| 02/22/2012 | EP2419443A2 Protein matrix for light-initiated electron transfer |
| 02/22/2012 | EP2419442A1 3d matrices of human elastin-like polypeptides and method of preparation thereof |
| 02/22/2012 | EP2419441A1 Dig-3 insecticidal cry toxins |
| 02/22/2012 | EP2419440A1 Peptide ligands for clusterin and uses thereof |
| 02/22/2012 | EP2419439A1 Cosmetic and/or pharmaceutical composition comprising a relieving peptidic hydrolysate |
| 02/22/2012 | EP2419438A1 Cosmetic and/or pharmaceutical composition comprising a peptidic hydrolysate that can reinforce the barrier function |
| 02/22/2012 | EP2419129A2 Compositions for immunising against staphylococcus aerus |
| 02/22/2012 | EP2419123A1 Novel post-translational fibrinogen variants |
| 02/22/2012 | EP2419121A2 Peptides targeting tnf family receptors and antagonizing tnf action, compositions, methods and uses thereof |
| 02/22/2012 | EP2419120A2 Human protein scaffold with controlled serum pharmacokinetics |
| 02/22/2012 | EP2419119A1 Muscle function enhancing peptide |
| 02/22/2012 | EP2390261A9 Modified human thrombopoietin polypeptide fragment and manufacturing method thereof |
| 02/22/2012 | EP2371840A9 Novel polypeptide having angiogenesis-inducing activity and antibacterial activity, and use thereof for medical purposes |
| 02/22/2012 | EP2102335B1 Purification of factor xi |
| 02/22/2012 | EP2010565B1 Method for recombinant protein production in cho cells |
| 02/22/2012 | EP1968623B1 Bacteriocin inducer peptides |
| 02/22/2012 | EP1803732B1 Peptides and apl-type derivatives of hsp60 and pharmaceutical compositions |
| 02/22/2012 | EP1740608B1 Modified human growth hormone polypeptides and their uses |
| 02/22/2012 | EP1668156B9 Method of diagnosing breast cancer |
| 02/22/2012 | EP1648496B1 Method for stabilizing a cryoprecipitate of plasmatic proteins for being subjected to a viral inactivation thermal treatment |
| 02/22/2012 | EP1608767B1 Optimized expression of hpv 31 l1 in yeast |
| 02/22/2012 | EP1572234B1 STABILIZED IMMUNOGENIC HBc CHIMER PARTICLES |
| 02/22/2012 | EP1531850B1 Use of IL-21 and monoclonal antibody for treating solid cancers |
| 02/22/2012 | EP1390381B1 Lipid metabolism regulators in plants |
| 02/22/2012 | EP0979080B9 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 02/22/2012 | CN1980695B 抗原递送载体和构建物 Antigen delivery vectors and constructs |
| 02/22/2012 | CN1688702B 表达rna病毒抗原表位的重组麻疹病毒在制备疫苗组合物中的用途 Expression rna viral epitopes in the preparation of a recombinant measles virus vaccine composition of use |
| 02/22/2012 | CN1642976B 一种突变的免疫球蛋白-结合蛋白 A mutant immunoglobulin - binding protein |
| 02/22/2012 | CN102361984A Novel bacillus thuringiensis gene with lepidopteran activity |
| 02/22/2012 | CN102361983A Novel bacillus thuringiensis gene with lepidopteran activity |
| 02/22/2012 | CN102361982A Novel bacillus thuringiensis gene with lepidopteran activity |
| 02/22/2012 | CN102361883A Bispecific anti-erbb-1/anti-c-met antibodies |
| 02/22/2012 | CN102361648A Salmonella marker vaccine |
| 02/22/2012 | CN102361646A Compounds and methods for modulating immune response |
| 02/22/2012 | CN102360013A ELISA kit for detecting duck plague virus antibody, and antibody detection method thereof |
| 02/22/2012 | CN102360008A Kit based on duck plague virus gG segmented recombinant protein and its application |
| 02/22/2012 | CN102358904A Arabidopsis thaliana WRKY57 gene and preparation method and application in improving crop drought resistance thereof |
| 02/22/2012 | CN102358895A Monoclonal antibody mcf2 and application thereof |
| 02/22/2012 | CN102358753A Trypsin inhibitor active fragment derivative, and preparation method and application thereof |
| 02/22/2012 | CN102358752A GLP-1 and exendin related invention |
| 02/22/2012 | CN102357062A Compositions and methods for topical application and transdermal delivery of botulinum toxins |
| 02/22/2012 | CN101985470B 胰高血糖素样多肽-1类似物及其制备方法与应用 Glucagon-like peptide 1 analog and preparation method and application |
| 02/22/2012 | CN101891808B 水稻根长发育控制基因OsSPR1编码的基因及蛋白质 Rice root growth and development control genes and proteins encoded by the gene OsSPR1 |
| 02/22/2012 | CN101851282B 植物耐逆性相关蛋白MtCBF4及其编码基因和应用 Stress tolerance of plants and their associated protein-coding genes and application MtCBF4 |
| 02/22/2012 | CN101747419B 耐盐相关蛋白及其编码基因与应用 Salt-related protein and its encoding gene and application |
| 02/22/2012 | CN101613403B 用大麦麦芽蛋白制备抗菌蛋白的方法 Barley malt protein preparation method of antibacterial proteins |
| 02/22/2012 | CN101508732B 一种从毛蚶中分离纯化血红蛋白的方法 A method of separating from purified hemoglobin Clam |
| 02/22/2012 | CN101182353B 水稻耐逆性相关受体类蛋白OsSIK1及其编码基因与应用 Stress tolerance in rice-related receptor protein-coding gene and application OsSIK1 |
| 02/22/2012 | CN101081862B β天花粉蛋白的快速纯化及其结晶技术 rapid purification of β TCS and crystallization technology |
| 02/21/2012 | US8119786 Nucleic acids encoding CCL27 |
| 02/21/2012 | US8119783 FGF variants and methods for use thereof |
| 02/21/2012 | US8119776 Mutants of human fibroblast growth factor having increased stability and/or mitogenic potency |
| 02/21/2012 | US8119774 Cell marker for hepatic and pancreatic stem cells and progenitor cells |
| 02/21/2012 | US8119773 Compositions and methods for facilitating heme-iron export from cells |
| 02/21/2012 | US8119771 Products for altering IL-33 activity and methods thereof |
| 02/21/2012 | US8119770 Modified soluble FGF receptor Fc fusions with improved biological activity |
| 02/21/2012 | US8119769 Complement depletion using recombinant human C-3 derivatives |
| 02/21/2012 | US8119768 Compositions and methods for modulating AMPA receptor-mediated excitotoxicity |
| 02/21/2012 | US8119605 Soluble tumor necrosis factor receptor treatment of medical disorders |
| 02/21/2012 | US8119603 Modified human interferon polypeptides and their uses |
| 02/21/2012 | US8119601 Mitochondria protein; anticancer agents; antiproliferative agents; viricides |
| 02/21/2012 | US8119599 Enhancing non-denatured collagenous tissues to increase resistance to tearing, fissuring, rupturing, and/or delamination via genipin crosslinking treatment |
| 02/21/2012 | US8119598 Synthetic peptide materials for joint reconstruction, repair and cushioning |
| 02/21/2012 | US8119597 Non-neurotoxic plasminogen activating factors for treating of stroke |
| 02/21/2012 | US8119594 Method of modulating integrin mediated cellular activity and agents useful for same |
| 02/21/2012 | US8119593 Method of treating diabetes type 2 by metformin and an ultrarapid acting insulin |
| 02/21/2012 | US8119590 Apolipoprotein A-I (ApoA-I), preferably a variant form such as Apolipoprotein A-I Milano (ApoA-IM), alone or more preferably in combination with a lipid carrier such as phospholipids or other drug, can be administered locally |
| 02/21/2012 | US8119589 Modulation of CD4+ T cell responses by a tick saliva protein, Salp15 and polypeptides derived therefrom |
| 02/21/2012 | US8119410 Apoptosis modulator Bcl-B and methods for making and using same |
| 02/21/2012 | US8119404 Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them |
| 02/21/2012 | US8119402 Methods of inhibiting T1R1/T1R3 heteromeric umami taste receptors |
| 02/21/2012 | US8119401 IL-10 gene transfer to peripheral mononuclear cells |
| 02/21/2012 | US8119395 Vaccines, immunotherapeutics and methods for using the same |
| 02/21/2012 | US8119381 Rationally-designed meganucleases with altered sequence specificity and DNA-binding affinity |
| 02/21/2012 | US8119380 Methods and materials for making and using transgenic dicamba-degrading organisms |
| 02/21/2012 | US8119370 Activatable recombinant neurotoxins |
| 02/21/2012 | US8119366 Antennapedia-dominant negative mastermind-like construct |
| 02/21/2012 | US8119361 Methods of cleaving DNA with rationally-designed meganucleases |
| 02/21/2012 | US8119359 Methods of indentifying sweet taste modulators |
| 02/21/2012 | US8119354 Cell-free assay product and method of use thereof for measuring activity of frizzled receptors |
| 02/21/2012 | US8119340 Methods and compositions for diagnosis and treatment of B cell chronic lymphocytic leukemia |
| 02/21/2012 | US8119147 Compositions produced using enteric pathogens and methods of use |
| 02/21/2012 | US8119119 Retroviral vector for improving exogenous gene transfer and expression in cells |
| 02/21/2012 | US8119118 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 02/21/2012 | US8119117 Adenoviral expression vector comprising a CD40L fusion protein adapted to elicit cellular immunity |
| 02/21/2012 | US8119114 Polymer conjugates of mutated neublastin |
| 02/21/2012 | CA2675025C Inhibitor of herpesvirus infection, method for inhibition of herpesvirus infection, and use thereof |
| 02/21/2012 | CA2615833C Growth-stimulating polypeptides for use in fish and crustaceans |
| 02/21/2012 | CA2487362C Use of an interleukin 1 receptor antagonist and/or pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes |